These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5864379)

  • 1. [Treatment of OIA ovarian ascitic epithelioma by oxygen-peritoneum combined with a cytostatic drug (triethylene melamine)].
    Rivenzon A; Comişel V; Rivenzon M
    Oncologia; 1965; 19(4):321-5. PubMed ID: 5864379
    [No Abstract]   [Full Text] [Related]  

  • 2. Triethylene melamine in the management of far advanced ovarian cancer.
    SYKES MP; RUNDLES RW; PIERCE VK; KARNOFSKY DA
    Surg Gynecol Obstet; 1955 Aug; 101(2):133-40. PubMed ID: 14396722
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF HYPERBARIC OXYGEN AND CANCER CHEMOTHERAPY ON GROWTH OF ANIMAL TUMORS.
    DECOSSE JJ; ROGERS LS
    Surg Forum; 1964; 15():203-5. PubMed ID: 14189326
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumoricidal effects of sodium hexachloroiridate on an ascitic tumor in mice.
    Kolodny GM; Rose C
    Cancer Res; 1983 Jul; 43(7):3101-3. PubMed ID: 6682698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with triethylene melamine (TEM) and triethylene thiophosphoramide (thioTEPA) in recurrent or metastatic solid tumors.
    SCHELL RF; HALL BE
    Surg Gynecol Obstet; 1958 Apr; 106(4):459-65. PubMed ID: 13529522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Continuous peritoneal lavage with antiblastics in the treatment of ovarian carcinoma in the ascitic phase. Preliminary results].
    Vadalà G; Buffone A; Germenia M; Vadalà V; Giarlotta R; Caragliano V; Calì V
    Minerva Chir; 1984 Dec 15-31; 39(23-24):1689-91. PubMed ID: 6531118
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of malignant diseases with triethylene melamine].
    ROMEO ORBEGOZO JM
    Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
    [No Abstract]   [Full Text] [Related]  

  • 8. Urethane plus triethylene melamine therapy in human cancer cases.
    BLACK MM; SPEER FD
    N Y State J Med; 1954 May; 54(10):1477-80. PubMed ID: 13154643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report].
    BOLIO MONSREAL E
    Bol Liga Contra Cancer Havana; 1953 Jun; 28(3):56-62. PubMed ID: 13115509
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of retinoblastoma by radiation and triethylene melamine.
    REESE AB; HYMAN GA; MERRIAN CR; FORREST AW
    Trans Am Acad Ophthalmol Otolaryngol; 1957; 61(4):439-46. PubMed ID: 13467961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
    LUHRS W; SCHAMMEL J; LOTZ HH
    Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
    [No Abstract]   [Full Text] [Related]  

  • 12. [Triethylene melamine treatment of leukemia and lymphogranulomatosis].
    CAKMAKCI A
    Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of triethylene melamine in the treatment of neoplasms].
    DI PIETRO S
    Minerva Med; 1953 Mar; 44(19):585-92. PubMed ID: 13071885
    [No Abstract]   [Full Text] [Related]  

  • 14. The peritoneum as a novel oxygenation organ: revitalization of intraperitoneal oxygenation.
    Matsutani N; Takase B; Nogami Y; Ozeki Y; Ishihara M; Maehara T
    Shock; 2008 Sep; 30(3):250-3. PubMed ID: 18197147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The appearance of mitosis in the circulating blood during treatment of myeloid leukemia with triethylene melamine].
    BRUGSCH J; TICHTER E
    Z Gesamte Inn Med; 1954 Jun; 9(12):616-8. PubMed ID: 13206156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Practical results of use of triethylenemelamine in neoplastic diseases. IV. Lung neoplasms].
    LENTI G; GAVOSTO F
    G Ital Chemioter; 1954; 1(1):104-5. PubMed ID: 13191595
    [No Abstract]   [Full Text] [Related]  

  • 17. [First results of therapy with triethylene melamine].
    NOWOTNA-WALCOWA R
    Pol Tyg Lek (Wars); 1955 Feb; 10(5):149-51. PubMed ID: 14371117
    [No Abstract]   [Full Text] [Related]  

  • 18. [Triethylene melamine, a new agent in the treatment of cancer].
    ROCCHIETTA S
    Boll Chim Farm; 1952 Oct; 91(10):407-9. PubMed ID: 13032250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Two years experience with triethylene melamine].
    WEICKER B
    Medizinische; 1954 Dec; 49():1644-7. PubMed ID: 13235144
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents.
    Edelstein MB; Smink T; van Putten LM
    Behring Inst Mitt; 1984 May; (74):285-90. PubMed ID: 6477357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.